Based on data provided by the World Health Organisation, lower respiratory tract infections were the 5th most common cause of death in 2021 [1]. Research highlights the importance of mitochondrial respiration as a critical factor in the cellular immune response to viral inflammation [2]. Plant-derived nanovesicles (PDNV) have a unique structure – a double phospholipid layer - which protects bioactive substances inside the vesicle and improves their targeted delivery to affected cells [3].
This topic is relatively new, and therefore the aim of this study was to analyse the effect of PDNV on mitochondrial respiration during viral inflammation.
Methods: PDNV isolation by polymeric precipitation method; human bronchial epithelial cells (HBEC-3KT) cultivation; Seahorse XF Cell Mito Stress test; cell viability analysis with fluorescent microscopy using Hoechst 33342 dye and propidium iodide; Bradford method.
Cell viability analysis results revealed that none of the analysed Poly (I:C) concentrations (0.01, 0.025 ,0.05, 0.075, 0.1, 0.25, 0.5, 0.75 and 1 μg/ml) had a significant effect on cell viability. A concentration of 1 μg/ml Poly (I:C) was used for further experiments. It was determined that PNDV statistically significantly reduced the number of dead cells exposed to Poly (I:C) compared to a group affected by Poly (I:C) alone. A cellular mitochondrial respiration test showed that PNDV restored both maximum and baseline respiration in cells exposed to Poly (I:C) and PNDV, compared to a group exposed only to Poly (I:C)
Plant-derived nanovesicles have the potential to improve mitochondrial respiration during viral inflammation induced by Poly (I:C). These results indicate that PDNVs possess virus-fighting properties. Further research is needed to explore their potential applications in treating virus-induced lower respiratory infections.